Breaking News

You are here » Indian-Commodity  :  Equity & Shares  :  Ipca Laboratories surges on reporting over two fold jump in Q1 net profit

12-Aug2016

Ipca Laboratories surges on reporting over two fold jump in Q1 net profit

Ipca Laboratories is currently trading at Rs. 529.50, up by 6.45 points or 1.23% from its previous closing of Rs. 523.05 on the BSE.

The scrip opened at Rs. 529.00 and has touched a high and low of Rs. 532.45 and Rs. 525.10 respectively. So far 52008 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 888.00 on 19-Aug-2015 and a 52 week low of Rs. 402.00 on 06-Jun-2016.

Last one week high and low of the scrip stood at Rs. 537.40 and Rs. 493.75 respectively. The current market cap of the company is Rs. 6682.24 crore.

The promoters holding in the company stood at 45.90%, while institutions and non-institutions held 37.89% and 16.21% respectively.

Ipca Laboratories has reported over two fold jump in its net profit at Rs 47.57 crore for the quarter ended June 30, 2016 as compared to Rs 20.92 crore for the same quarter in the previous year. The company's total income increased by 11.19% to Rs 847.03 crore for the quarter under review from Rs 761.79 crore for the corresponding quarter of the previous year

Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company's income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.


Related News

View all news

Jammu & Kashmir Bank trades higher on the bourses

The Jammu & Kashmir Bank is currently trading at Rs. 42.65, up by 0.45 points or 1.07% from its previous closing of Rs. 42.20 on the BSE.The scrip opened at Rs. 42.25 and has touched a high and......

IndiGo trades in green on the BSE

Interglobe Aviation is currently trading at Rs. 843.65, up by 7.30 points or 0.87% from its previous closing of Rs. 836.35 on the BSE.The scrip opened at Rs. 848.10 and has touched a high and low of Rs.......

Mphasis slips despite reporting 37% rise in Q2 consolidated net profit

Mphasis is currently trading at Rs. 1070.00, down by 53.10 points or 4.73% from its previous closing of Rs. 1123.10 on the BSE.The scrip opened at Rs. 1107.00 and has touched a high and low of Rs. 1119.90......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......